Zhengye Biotechnology Holding (ZYBT) Long-Term Investments (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Long-Term Investments data on file, last reported at $30.5 million in Q4 2025.

• Long-Term Investments for Q4 2025 came in at $30.5 million, down 22.77% year-over-year; the trailing twelve-month figure through Dec 2025 was $30.5 million (down 22.77% YoY), and the FY2025 annual result was $31.0 million, down 20.42% from the prior year.
• Long-Term Investments slipped to $30.5 million in Q4 2025 per ZYBT's latest filing, from $39.5 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $39.5 million in Q4 2024 and troughed at $30.5 million in Q4 2025.
• A 3-year average of $36.0 million and a median of $37.9 million in 2023 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2024 and 2025: Long-Term Investments increased 4.32% in 2024, then slipped 22.77% in 2025.
• A 3-year view of Long-Term Investments shows it stood at $37.9 million in 2023, then grew by 4.32% to $39.5 million in 2024, then declined by 22.77% to $30.5 million in 2025.
• Business Quant data shows ZYBT's Long-Term Investments at $30.5 million in Q4 2025, $39.5 million in Q4 2024, and $37.9 million in Q4 2023.